Haematology pathway board 

The Haematology Tumour Pathway Board, led by Ronjon Chakraverty, is responsible for driving improvement across the whole care pathway.

  • Clinical director

    Ronjon Chakraverty

    Ronjon Chakraverty is a Clinician Scientist and Professor of Haematology and Cellular Immunotherapy at UCL.

    Following his training in Internal Medicine in Cambridge, he was awarded an MRC Clinical Training Fellowship at the Institute of Molecular Medicine in Oxford where he attained his PhD in 1998. He was then appointed as transplant fellow at University College Hospital London between 1998-2000, where he was involved in the initial clinical trials of reduced intensity conditioning for allogeneic haematopoietic stem cell transplantation. In 2000, he was awarded a Senior Research Fellowship in Experimental Haematology from Leukaemia & Lymphoma Research, which funded post-doctoral studies in the laboratory of Professor Megan Sykes at Harvard.Here, his research focused upon the biology of GvL responses following adoptive cellular therapy.

    In 2005, he returned to UCL where he attends as a transplant physician and has attained programme-level funding for research exploring (1) the mechanisms of tissue injury in GVHD and (2) the design of strategies for increasing the engraftment and persistence of therapeutic anti-tumour T cells. Key achievements have been the demonstration of the critical role of tissue ‘licensing’ in driving GVHD and the role of non-haematopoietic cells in driving eventual exhaustion of GvL effectors.


 Haematology pathway board papers

Haematology Pathway Board Minutes September 201805/09/2018
Haematology Pathway Board Minutes May 201809/05/2018
Haematology Pathway Board Minutes November 201730/11/2017
Haematology pathway board minutes June 201715/06/2017
Haematology pathway Board Minutes March 201708/03/2017
Haematology Pathway Board Minutes November 201630/11/2016

 Haematology pathway board documents

Pan London ALL Guidelines Sept 2018
Pan London AML Guidelines Sept 2018
Pan London CLL Guidelines Sept 2018
Pan London CML Guidelines Sept 2018
Pan London DLBCL Guidelines Sept 2018
Pan London FL Guidelines Sept 2018
Pan London Hodgkin Guidelines Sept 2018
Pan London Less Common Guidelines Sept 2018
Pan London MDS Guidelines Sept 2018
Pan London MPN Guidelines Sept 2018
Pan London Plasma Cell Guidelines Sept 2018
Haem Pathway Board Annual Report 2017-18

 Membership - Haematology pathway board

Adele FieldingConsultant HaematologistUCLH
Ali RismaniConsultant HaematologistWhittington Health
Beth PayneSenior Clinical Researcher/Clinical ConsultantUCLH/UCL
Bianca O'DonnellPatient RepresentativePatient Representative
Derralynn HughesConsultant HaematologistRoyal Free London
Finbarr CotterLead for Molecular Pathology & Head of Experimental HaematologyQMUL/Barts Health
Gilly AngellPatient RepresentativePatient Representative
Hassan Al-AshimiGeneral PractitionerGP
Heather OakerveeClinical Senior LecturerBarts Health
Jane MorrisPatient RepresentativePatient Representative
John GribbenConsultant HaematologistBarts Health
Manuel Rodriguez JustoPathologistUCLH
Maria CalaminiciConsultant PathologistBarts Health
Marie ScullyConsultant PathologistUCLH
Matthew SmithConsultant Haematology-OncologyBarts Health
Neil ChauhanConsultant HaematologistHomerton University Hospital
Neil RabinConsultant HaematologistNorth Middlesex University Hospital / UCLH
Peter BionPatient RepresentativePatient Representative
Rakesh PopatUCLHUCLH
Rebecca AuerConsultant HaematologistBarts Health
Ronjon ChakravertyConsultant Haematologist / Pathway Board DirectorUCLH / Royal Free
Samir AgrawalSenior Lecturer/Honorary ConsultantBarts Health
Sandra HassanConsultant HaematologistBarking, Havering and Redbridge University Trust
Teresa MarafiotiHaematopathologistUCLH
Tom ButlerConsultant HaematologistBarts Health
Vicky GrandageConsultant HaematologistUCLH
Wai Keong KongConsultant HaematologistUCLH